Skip to content
Screener

Annexon ANNX Financing Cash Flow

Financing Cash Flow at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
-$1.22B-8.5%
Omeros logo
OmerosOMER
-$21.98M-1,095%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$128.01M
Jade Biosciences logo
Jade BiosciencesJBIO
-$795K-13.6%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$739.41M+459,161%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$1.1M+195%

Other financials

Income statement

See full
Operating income-$46.1M+19.8%
Net income-$44.1M+18.8%
EPS (diluted)-$0.23+37.8%

Balance sheet

See full
Cash & equivalents$175.2M+80.4%
Total debt$25.4M-10.2%
Total equity$204.5M-16.1%
Total assets$262.9M-13.2%

Cash flow

See full
Operating cash flow-$46.8M+6.5%
CapEx--100%
Free cash flow-$46.8M+6.6%

Valuation

See full
Market cap$886.39M+244%
Enterprise value$736.61M+381%

Returns & leverage

See full
Return on equity-87.6%+42.3pp
Debt / equity0.1×0.0×
Current ratio6.4×-1.6×

Where this comes from

Reported directly by Annexon in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: Annexon’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211931
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Proceeds from the exercise of common stock options22962
Proceeds from the issuance of common stock33,603
Payment of financing costs(936)(3)
Net cash provided by financing activities32,89659
Increase in cash, cash equivalents and restricted cash13,15647,624
Effect of exchange rate changes on cash, cash equivalents and restricted cash1
Cash, cash equivalents and restricted cash
Beginning of period163,08350,530

Cover / Front Matter

FAQ

What is Annexon's financing cash flow?
Annexon (ANNX) reported financing cash flow of $32.9M in Q1 2026.
How has Annexon's financing cash flow changed year-over-year?
Annexon's financing cash flow increased by 55655.9% year-over-year, from $59K to $32.9M.
What is the long-term trend for Annexon's financing cash flow?
Over 4 years (2021 to 2025), Annexon's financing cash flow has grown at a 176.3% compound annual growth rate (CAGR), from $1.87M to $108.86M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about Annexon's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude